Identification of cell-active lysine specific demethylase 1-selective inhibitors.

@article{Ueda2009IdentificationOC,
  title={Identification of cell-active lysine specific demethylase 1-selective inhibitors.},
  author={Rie Ueda and Takayoshi Suzuki and Koshiki Mino and Hiroki Tsumoto and Hidehiko Nakagawa and Makoto Hasegawa and Ryuzo Sasaki and Tamio Mizukami and Naoki Miyata},
  journal={Journal of the American Chemical Society},
  year={2009},
  volume={131 48},
  pages={
          17536-7
        }
}
Lysine specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the methyl groups from methylated Lys4 of histone H3 (H3K4). Here we report the identification of the first small-molecule LSD1-selective inhibitors. These inhibitors show in vivo H3K4-methylating activity and antiproliferative activity and should be useful as lead structures for anticancer drugs and as tools for studying the biological roles of LSD1. 

Figures, Tables, and Topics from this paper

LSD1 Histone Demethylase Assays and Inhibition.
TLDR
This chapter discusses several approaches to measure LSD1 demethylase activity and their relative strengths and limitations for inhibitor discovery and mechanistic characterization, and highlights a few examples of recently developed LSD1 mechanism-based inactivators and their biomedical applications. Expand
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.
TLDR
On the basis of these substrate mimicking inhibitors, a combination of similarity-based virtual screening and subsequent synthetic optimization resulting in more druglike LSD1 inhibitors that led to histone hypermethylation in breast cancer cells is reported. Expand
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.
TLDR
A series of small molecule amidoximes that are moderate inhibitors of recombinant LSD1 but that produce dramatic changes in methylation at the histone 3 lysine 4 (H3K4) chromatin mark, a specific target of LSD1, in Calu-6 lung carcinoma cells are reported. Expand
Drug Design Concepts for LSD1-Selective Inhibitors.
TLDR
The authors' LSD1 inhibitors show not only potent LSD1-selective inhibitory activities, but also unique bioactivities both in’vitro and in vivo. Expand
Inhibitors of histone demethylases.
TLDR
The enzymes involved in demethylation have recently been discovered and found to be involved in cancer development and progression and a number of inhibitors have already appeared. Expand
Design, synthesis, and biological activity of N-alkylated analogue of NCL1, a selective inhibitor of lysine-specific demethylase 1
TLDR
An N-alkylated analogue of NCL1 is designed and synthesized and exhibited cell growth inhibition in cervical cancer HeLa cell line and neuroblastoma SH-SY5Y cell line, and should be useful as a lead structure for anticancer drugs. Expand
(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.
TLDR
A series of isosteric ureas and thioureas that are also potent inhibitors of LSD1 and induce increases in methylation at the histone 3 lysine 4 chromatin mark in Calu-6 lung carcinoma cells represent an important new series of epigenetic modulators with the potential for use as antitumor agents. Expand
Histone Lysine Demethylase Inhibitors.
TLDR
This review will briefly outline the connection between demethylases and cancer and will provide a comprehensive overview of the structure, specificity, and utility of currently available demethylase inhibitors. Expand
Pharmacological Inhibition of LSD1 for Cancer Treatment
TLDR
This review will present the structural aspects of LSD1, its role in carcinogenesis, a comparison of currently available approaches for screening LSD1 inhibitors, a classification of LSD 1 inhibitors, and its potential as a drug target in cancer therapy. Expand
Synthesis of artificial substrate based on inhibitor for detecting LSD1 activity
TLDR
Artificial substrates based on inhibitors of LSD1 to examine LSD1 activity by an absorption increment are designed and synthesized and used as chemical tools to research biological significance of LSD 1 in physiological and pathological events. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 12 REFERENCES
A mechanism-based inactivator for histone demethylase LSD1.
TLDR
Two peptide-based inhibitor analogues that block LSD1 are designed and synthesized and one contains a propargylamine functionality and shows time-dependent inactivation of LSD1, likely to serve as a useful tool in the study of histone modifications and chromatin remodeling. Expand
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.
TLDR
Structural and mass spectrometry analyses are consistent with PCPA forming a covalent adduct with FAD in LSD1 that is distinct from the FAD-PCPA adduct of MAO B, and the structure reveals that the phenyl ring of the F adduct in LSD 1 does not form extensive interactions with active-site residues. Expand
The Lysine-specific Demethylase 1 Is Required for Cell Proliferation in Both p53-dependent and -independent Manners*
TLDR
It is found that deficiency in LSD1 leads to a partial cell cycle arrest in G2/M and sensitizes cells to growth suppression induced by DNA damage or MDM2 inhibition in a p53-dependent manner. Expand
Histone lysine demethylases: emerging roles in development, physiology and disease
  • Yang Shi
  • Biology, Medicine
  • Nature Reviews Genetics
  • 2007
The discovery of an increasing number of histone demethylases has highlighted the dynamic nature of the regulation of histone methylation, a key chromatin modification that is involved in eukaryoticExpand
Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes
TLDR
It is reported that novel biguanide and bisguanidine polyamine analogues are potent inhibitors of LSD1 in human colon carcinoma cells and affect a reexpression of multiple, aberrantly silenced genes important in the development of colon cancer, including members of the secreted frizzle-related proteins (SFRPs) and the GATA family of transcription factors. Expand
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation
TLDR
The crystal structure of human LSD1 with a propargylamine-derivatized H3 peptide covalently tethered to FAD is reported and the unusual backbone conformation of LSD1-bound H3 suggests a strategy for designing potent LSD1 inhibitors with therapeutic potential. Expand
Transrepressive Function of TLX Requires the Histone Demethylase LSD1
TLDR
The present study suggests that LSD1 is a prime corepressor for TLX, which appears to form a complex with CoREST and histone deacetylase 1 and potentiated the transrepressive function of TLX through its histone demethylase activity. Expand
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
TLDR
It is shown that lysine-specific demethylase 1 co-localizes with the androgen receptor in normal human prostate and prostate tumour and pargyline is identified as an inhibitor of LSD1, providing a mechanism by which demethylases control specific gene expression. Expand
Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures
TLDR
The 1.7-Å structure of the reversible isatin–MAO-B complex has been determined; it forms a basis for the interpretation of the enzyme's structure when bound to either reversible or irreversible inhibitors. Expand
Epigenetic control using natural products and synthetic molecules.
TLDR
This review presents natural products and synthetic molecules that inhibit or activate enzymes catalyzing DNA methylation or histone modifications, and discusses the potential of epigenetic therapy. Expand
...
1
2
...